Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression

Lang, LW; Shull, AY; Teng, Y

Teng, Y (reprint author), Augusta Univ, Dept Oral Biol, 1120 15th St, Augusta, GA 30912 USA.

CURRENT CANCER DRUG TARGETS, 2019; 19 (1): 17

Abstract

Coordination between the amplification of the fibroblast growth factor FGF19, overexpression of its corresponding receptor FGFR4, and hyperactivation ......

Full Text Link